March 11, 2011      

Accuray (Nasdaq: ARAY), a provider of robotic radiosurgery in Sunnyvale, Calif., and TomoTherapy Incorporated (Nasdaq: TOMO), creator of radiation therapy solutions for cancer care in Madison, Wisc., have signed a definitive agreement under which Accuray will acquire TomoTherapy for $4.80 per share in cash and stock, or a total of approximately $277 million.

The transaction combines technologies from two high-growth companies, which currently serve complementary patient populations that are tre...

Thank You for Reading Robotics Business Review!

Reading this content requires a free membership.
To continue reading, please sign up for an RBR Insider account.